Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver

I am writing in my capacity as the President of EFPIA, the European Federation of Pharmaceutical industries and Associations, and as Chairman of the Executive Board and CEO of Merck. I would like to express my deepest concern with the ongoing debate on the proposal to amend the Supplementary Protection Certificate (SPC) Regulation to introduce an SPC manufacturing waiver.